Pancreatic ductal adenocarcinoma (PDAC) is considered as one of the most aggressive malignancies due to its unique microenvironment of which the cardinal histopathological feature is the remarkable desmoplasia of the stroma, taking up about 80% of the tumor mass. The desmoplastic stroma negatively affects drug diffusion and the infiltration of T cells, leading to an immunosuppressive microenvironment. However, this unique microenvironment can limit the physical spread of pancreatic cancer via a neighbor suppression effect. Here, a tumor central stroma targeting and microenvironment responsive strategy was applied to generate a nanoparticle coloading paclitaxel and phosphorylated gemcitabine. The designed nanoparticle disrupted the central s...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Pancreatic cancer is one of the deadliest types of cancer, with a five-year survival rate of only 10...
Despite improvements in our understanding of pancreatic cancer and the emerging concept of personali...
Pancreatic cancer is one of the most malignant tumors with one of the worst survival rates due to it...
A nearly impenetrable stroma and hypovascularity limit drug delivery to pancreatic ductal adenocarci...
Making up just over 3% of all new cancer cases in the United States, pancreatic cancer is not inhere...
Abstract Pancreatic cancer is one of the most lethal malignant tumors with a low survival rate, part...
Pancreatic ductal adenocarcinoma (PDAC) elicits a dense stromal response that blocks vascular access...
<p>The unique tumour microenvironment (TM) of pancreatic ductal adenocarcinoma (PDA) including highl...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers worldwide, primarily due to i...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with an extremely poor prognosis...
To better make nanomedicine entering the clinic, developing new rationally designed nanotherapeutics...
Here, we fabricated nanoparticles made solely from the membrane of cells found in the pancreatic tum...
Pancreatic ductal adenocarcinoma (PDAC) is rare and difficult to treat, making it a complicated diag...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult cancers to treat. It is re...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Pancreatic cancer is one of the deadliest types of cancer, with a five-year survival rate of only 10...
Despite improvements in our understanding of pancreatic cancer and the emerging concept of personali...
Pancreatic cancer is one of the most malignant tumors with one of the worst survival rates due to it...
A nearly impenetrable stroma and hypovascularity limit drug delivery to pancreatic ductal adenocarci...
Making up just over 3% of all new cancer cases in the United States, pancreatic cancer is not inhere...
Abstract Pancreatic cancer is one of the most lethal malignant tumors with a low survival rate, part...
Pancreatic ductal adenocarcinoma (PDAC) elicits a dense stromal response that blocks vascular access...
<p>The unique tumour microenvironment (TM) of pancreatic ductal adenocarcinoma (PDA) including highl...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers worldwide, primarily due to i...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with an extremely poor prognosis...
To better make nanomedicine entering the clinic, developing new rationally designed nanotherapeutics...
Here, we fabricated nanoparticles made solely from the membrane of cells found in the pancreatic tum...
Pancreatic ductal adenocarcinoma (PDAC) is rare and difficult to treat, making it a complicated diag...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult cancers to treat. It is re...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Pancreatic cancer is one of the deadliest types of cancer, with a five-year survival rate of only 10...
Despite improvements in our understanding of pancreatic cancer and the emerging concept of personali...